Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$601M |
| 2 |
Parker-Hannifin
PH
|
+$576M |
| 3 |
JPMorgan Chase
JPM
|
+$575M |
| 4 |
Goldman Sachs
GS
|
+$452M |
| 5 |
FedEx
FDX
|
+$371M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$733M |
| 2 |
American Tower
AMT
|
+$684M |
| 3 |
Nike
NKE
|
+$601M |
| 4 |
AGN
Allergan plc
AGN
|
+$561M |
| 5 |
McDonald's
MCD
|
+$536M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 17.46% |
| 3 | Healthcare | 13.37% |
| 4 | Communication Services | 12.12% |
| 5 | Financials | 11.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
D.R. Horton
DHI
$41.3B
| $831K | ﹤0.01% |
+30,414
| New | +$869K |
|
|
BNY
627
Bank of New York Mellon
BNY
$107B
| $818K | ﹤0.01% |
+17,272
| New | +$779K |
|
628
Alexandria Real Estate Equities
ARE
$8.96B
| $805K | ﹤0.01% |
+7,241
| New | +$777K |
|
629
Crown Holdings
CCK
$12.9B
| $802K | ﹤0.01% |
+15,251
| New | +$824K |
|
630
General Motors
GM
$78.7B
| $801K | ﹤0.01% |
+22,993
| New | +$773K |
|
|
BRKL
631
DELISTED
Brookline Bancorp
BRKL
| $787K | ﹤0.01% |
48,008
-1,327
| -3% | -$19K |
|
632
Caesarstone
CSTE
$75.7M
| $771K | ﹤0.01% |
+26,928
| New | +$855K |
|
|
SCHW
633
Charles Schwab
SCHW
$181B
| $769K | ﹤0.01% |
+19,476
| New | +$696K |
|
|
XLRN
634
DELISTED
Acceleron Pharma
XLRN
| $767K | ﹤0.01% |
+30,041
| New | +$952K |
|
635
Ford
F
$58.5B
| $766K | ﹤0.01% |
+63,129
| New | +$766K |
|
636
Danaher
DHR
$138B
| $765K | ﹤0.01% |
11,088
-33,829
| -75% | -$2.35M |
|
637
Blackrock
BLK
$165B
| $751K | ﹤0.01% |
+1,974
| New | +$724K |
|
638
Vera Bradley
VRA
$106M
| $746K | ﹤0.01% |
+63,642
| New | +$876K |
|
639
PayPal
PYPL
$49.5B
| $717K | ﹤0.01% |
+18,158
| New | +$730K |
|
|
ESRX
640
DELISTED
Express Scripts Holding Company
ESRX
| $701K | ﹤0.01% |
10,195
-28,346
| -74% | -$2.03M |
|
|
AZPN
641
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $700K | ﹤0.01% |
+12,798
| New | +$700K |
|
642
Helmerich & Payne
HP
$3.36B
| $697K | ﹤0.01% |
+9,008
| New | +$640K |
|
643
Illinois Tool Works
ITW
$81.9B
| $689K | ﹤0.01% |
+5,627
| New | +$680K |
|
644
Abeona Therapeutics
ABEO
$349M
| $686K | ﹤0.01% |
+5,656
| New | +$886K |
|
|
KTWO
645
DELISTED
K2M Group Holdings, Inc
KTWO
| $675K | ﹤0.01% |
33,665
-934
| -3% | -$17.7K |
|
646
Northrop Grumman
NOC
$77.8B
| $672K | ﹤0.01% |
+2,889
| New | +$672K |
|
647
Syndax Pharmaceuticals
SNDX
$1.82B
| $672K | ﹤0.01% |
93,783
-289,993
| -76% | -$3.18M |
|
648
Kimberly-Clark
KMB
$37B
| $664K | ﹤0.01% |
+5,818
| New | +$675K |
|
649
CME Group
CME
$92.3B
| $632K | ﹤0.01% |
+5,482
| New | +$610K |
|
650
Johnson Controls International
JCI
$87.5B
| $629K | ﹤0.01% |
+15,270
| New | +$669K |
|
Similar funds
Jennison Associates's Q4 2016 Portfolio in Review
As of Q4 2016, Jennison Associates held 857 positions worth $89.6B, down 3.4% from $92.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jennison Associates withdrew a net $3.76B in Q4 2016, closing 52 positions and reducing 313 holdings. Its most notable exit was lululemon athletica, an estimated $342M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Parker-Hannifin worth $606M.
- Jennison Associates's largest Q4 2016 buy was Parker-Hannifin: 4,330,276 shares worth $606M.
- Jennison Associates added most to Charter Communications in Q4 2016, an estimated $601M increase.
- Jennison Associates's biggest Q4 2016 reduction was Biogen, cutting an estimated $733M.
- Jennison Associates fully exited lululemon athletica in Q4 2016, selling an estimated $342M.
- Jennison Associates's ten largest holdings make up 25% of its $89.6B portfolio in Q4 2016.
- Jennison Associates opened 208 new positions and closed 52 in Q4 2016.
- Jennison Associates's portfolio value fell 3.4% quarter-over-quarter to $89.6B.
Based on Jennison Associates's 13F filing for Q4 2016, filed 6 Feb 2017.